Mary Jessel, PhD, MBA

VP, Global Medical Affairs at Telix Pharmaceuticals

Speaker

Dr. Jessel has over 10 years’ of pharmaceutical, biotechnology and drug development experience and leads Telix Pharmaceutical’s Global Medical Affairs, Pharmacovigilance, Medical Information, Medical Communications on a global basis.

Before joining Telix Pharmaceuticals, she led research at the University of California, San Francisco in Leukodystrophies and led launch efforts at Ionis Pharmaceuticals and Akcea Therapeutics in the rare disease space, and supported drug development at Alcamena Stem Cell Therapeutics. Her expertise lies in Medical Affairs business strategy and building a first-class Medical Affairs team and infrastructure in theranostic, rare diseases, and oncology space in early to mid-size Companies.